Mid-Cap Stock Picks With Anil Singhvi: Aarti Surfactants, Greaves Cotton and FDC are top recommendations

In the popular Special Mid-Cap Stock Picks show, Zee Business Managing Editor Anil Singhvi spoke to market expert Ashish Kukreja on Tuesday and asked him to reveal his stock picks for the day that would generate good returns for investors. Kukreja responded with 3 - Aarti Surfactants, Greaves Cotton and FDC

Long Term Pick: Aarti Surfactants

The company belongs to Aarti Group and it is an extremely good scalable business. Promoters of the company are aggressively increasing stake in the company. Promoters and Management of all the group companies is extremely strong. Capacities of the company are increasing aggressively indicating that the business will do well going forward. Surfactant is one of the key ingredients used in Baby care, Home care and key segments by Pharma companies as well. The company is trading at attractive valuations. The target price on the stock is Rs 1800 – Rs 1850, time frame on this stock is 6 months to 1 year.

See Zee Business Live TV Streaming Below:

Positional Term pick: Greaves Cotton

The big push by the Government on the electric vehicle (EV) space will benefit this company. The company has a strong dealer network and it is going to gain huge benefit from 2 wheeler space going forward. The company has 50000 customers and has a good sense of distribution. Execution remains a key for this company as the opportunity for growth is humongous in EV space. The positional target on this stock is Rs 200 and can be a potential multibagger going forward as well.

शॉर्ट टर्म हो या पोजीशनल या लॉन्ग टर्म...इन मिडकैप शेयरों में बनेगा पैसा दमदार

आशीष कुकरेजा से जानिए दमदार फंडामेंटल वाले 3 बेहतरीन मिडकैप स्टॉक्स#SPLMidcapStocks #Longterm #Shares @AnilSinghvi_ @Ashishmuse pic.twitter.com/38LGrDDJIN

— Zee Business (@ZeeBusiness) April 13, 2021

Short term pick: FDC

FDC is a forerunner in manufacturing and marketing of Oral Rehydration Salts (ORS) and Ophthalmics. FDC has also set-up globally approved, multi-location manufacturing facilities for Active Pharmaceuticals Ingredients (APIs) as well as Finished Dosage Forms. The partnership firm was incorporated In 1936. It has its presence in numerous therapeutic segments: anti-infectives, gastrointestinals, ophthalmologicals, vitamins/ minerals/ dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, analgesics and others. The company has a strong brand name. FDC’s Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm are leading brands in their respective segments in India. These brands are growing extremely well in India and will continue to do well. Demand for key company’s products will remain strong going forward as well. Valuations of the company are attractive at current levels and it is a strong R&D company. New product launches will ensure turnaround for the company in future. The company has potential to be a big pharma company going forward. The target price on the stock is Rs 400.